In the BioHarmony Drug Report Database

"Preview" Icon

Rifaximin

Xifaxan (rifaximin) is a small molecule pharmaceutical. Rifaximin was first approved as Xifaxan on 2004-05-25. It is used to treat bacterial infections, diarrhea, and irritable bowel syndrome in the USA. Xifaxan’s patents are valid until 2029-10-02 (FDA).

 

Trade Name

 

Xifaxan
 

Common Name

 

rifaximin
 

ChEMBL ID

 

CHEMBL1617
 

Indication

 

bacterial infections, diarrhea, irritable bowel syndrome
 

Drug Class

 

Antibiotics (rifamycin derivatives)

Image (chem structure or protein)

Rifaximin structure rendering